Cargando…
Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers
BACKGROUND: While BRCA1/BRCA2 pathogenic sequence variants (PSVs) clearly confer an increased risk for invasive breast cancer, the extent to which these mutant alleles increase DCIS risk is less clear. OBJECTIVE: To assess the rate of detection over a 5-year period, and MRI imaging features of pure...
Autores principales: | Faermann, Renata, Friedman, Eitan, Kaidar-Person, Orit, Weidenfeld, Jonathan, Brodsky, Malka, Shalmon, Anat, Halshtok Neiman, Osnat, Gotlieb, Michael, Yagil, Yael, Samoocha, David, Madorsky Feldman, Dana, Sklair-Levy, Miri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633198/ https://www.ncbi.nlm.nih.gov/pubmed/36349178 http://dx.doi.org/10.1155/2022/4317693 |
Ejemplares similares
-
COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases
por: Faermann, Renata, et al.
Publicado: (2021) -
Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?
por: Bernstein-Molho, Rinat, et al.
Publicado: (2019) -
‘Earlier than Early’ Detection of Breast Cancer in Israeli BRCA Mutation Carriers Applying AI-Based Analysis to Consecutive MRI Scans
por: Anaby, Debbie, et al.
Publicado: (2023) -
DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3
por: Yang, Rachel L., et al.
Publicado: (2015) -
Immediate Breast Reconstruction for All?
por: Jacobson, Galia, et al.
Publicado: (2020)